Fig. 4.
Fig. 4. (A) Western blot analysis of VEGF-A in culture supernatants of HUT 78 cells incubated with HIV-TCM or TCM. HUT 78 cells were incubated in medium containing 25% of TCM or HIV-TCM. After 5 days of incubation, the cell culture supernatants were collected, concentrated, and subjected to SDS-PAGE under reducing conditions. Electroblotting and immunostaining were performed as described in Materials and Methods. A total of 10 ng of human recombinant VEGF165 was used as a control on the same membrane (rV). Two prominent bands corresponding to unglycosylated and glycosylated VEGF165 protein (24 and 26 kD, two upper bands) and a weaker band corresponding to glycosylated VEGF121 (20 kD, lower band) were detected in the cell culture supernatants. (B) Densitometric evaluation of band intensities from the Western blot shown in (A) indicates a 1.8-fold higher concentration of VEGF-A in HUT 78 cells after incubation with HIV-TCM as compared with incubation with TCM.

(A) Western blot analysis of VEGF-A in culture supernatants of HUT 78 cells incubated with HIV-TCM or TCM. HUT 78 cells were incubated in medium containing 25% of TCM or HIV-TCM. After 5 days of incubation, the cell culture supernatants were collected, concentrated, and subjected to SDS-PAGE under reducing conditions. Electroblotting and immunostaining were performed as described in Materials and Methods. A total of 10 ng of human recombinant VEGF165 was used as a control on the same membrane (rV). Two prominent bands corresponding to unglycosylated and glycosylated VEGF165 protein (24 and 26 kD, two upper bands) and a weaker band corresponding to glycosylated VEGF121 (20 kD, lower band) were detected in the cell culture supernatants. (B) Densitometric evaluation of band intensities from the Western blot shown in (A) indicates a 1.8-fold higher concentration of VEGF-A in HUT 78 cells after incubation with HIV-TCM as compared with incubation with TCM.

Close Modal

or Create an Account

Close Modal
Close Modal